These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12867596)

  • 1. Role of extracellular subdomains of p185c-neu and the epidermal growth factor receptor in ligand-independent association and transactivation.
    Kumagai T; Katsumata M; Hasegawa A; Furuuchi K; Funakoshi T; Kawase I; Greene MI
    Proc Natl Acad Sci U S A; 2003 Aug; 100(16):9220-5. PubMed ID: 12867596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of distinct p185neu extracellular subdomains for dimerization with the epidermal growth factor (EGF) receptor and EGF-mediated signaling.
    Kumagai T; Davis JG; Horie T; O'Rourke DM; Greene MI
    Proc Natl Acad Sci U S A; 2001 May; 98(10):5526-31. PubMed ID: 11320205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinase-deficient neu proteins suppress epidermal growth factor receptor function and abolish cell transformation.
    Qian X; Dougall WC; Hellman ME; Greene MI
    Oncogene; 1994 May; 9(5):1507-14. PubMed ID: 7908733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin.
    Pinkas-Kramarski R; Lenferink AE; Bacus SS; Lyass L; van de Poll ML; Klapper LN; Tzahar E; Sela M; van Zoelen EJ; Yarden Y
    Oncogene; 1998 Mar; 16(10):1249-58. PubMed ID: 9546426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of a naturally occurring EGFR oncoprotein by the p185neu ectodomain: implications for subdomain contributions to receptor assembly.
    O'Rourke DM; Nute EJ; Davis JG; Wu C; Lee A; Murali R; Zhang HT; Qian X; Kao CC; Greene MI
    Oncogene; 1998 Mar; 16(9):1197-207. PubMed ID: 9528862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p185c-neu and epidermal growth factor receptor associate into a structure composed of activated kinases.
    Quian XL; Decker SJ; Greene MI
    Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1330-4. PubMed ID: 1346931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of herstatin, an autoinhibitor of HER-2/neu, inhibits transactivation of HER-3 by HER-2 and blocks EGF activation of the EGF receptor.
    Azios NG; Romero FJ; Denton MC; Doherty JK; Clinton GM
    Oncogene; 2001 Aug; 20(37):5199-209. PubMed ID: 11526509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of signaling proteins with a nonmitogenic heterodimeric complex composed of epidermal growth factor receptor and kinase-inactive p185c-neu.
    Dougall WC; Qian X; Miller MJ; Greene MI
    DNA Cell Biol; 1996 Jan; 15(1):31-40. PubMed ID: 8561895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of the neu/p185 and EGF receptor tyrosine kinases: implications for cellular transformation and tumor therapy.
    Dougall WC; Qian X; Greene MI
    J Cell Biochem; 1993 Sep; 53(1):61-73. PubMed ID: 7901229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand release-independent transactivation of epidermal growth factor receptor by transforming growth factor-beta involves multiple signaling pathways.
    Joo CK; Kim HS; Park JY; Seomun Y; Son MJ; Kim JT
    Oncogene; 2008 Jan; 27(5):614-28. PubMed ID: 17637750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural analysis of p185c-neu and epidermal growth factor receptor tyrosine kinases: oligomerization of kinase domains.
    Murali R; Brennan PJ; Kieber-Emmons T; Greene MI
    Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6252-7. PubMed ID: 8692801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bivalence of EGF-like ligands drives the ErbB signaling network.
    Tzahar E; Pinkas-Kramarski R; Moyer JD; Klapper LN; Alroy I; Levkowitz G; Shelly M; Henis S; Eisenstein M; Ratzkin BJ; Sela M; Andrews GC; Yarden Y
    EMBO J; 1997 Aug; 16(16):4938-50. PubMed ID: 9305636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts.
    Kokai Y; Myers JN; Wada T; Brown VI; LeVea CM; Davis JG; Dobashi K; Greene MI
    Cell; 1989 Jul; 58(2):287-92. PubMed ID: 2568888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-independent and EGF receptor-supported transactivation: lessons from beta2-adrenergic receptor signalling.
    Drube S; Stirnweiss J; Valkova C; Liebmann C
    Cell Signal; 2006 Oct; 18(10):1633-46. PubMed ID: 16495036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-expression of ErbB-family members in human breast cancer: Her-2/neu is the preferred dimerization candidate in nodal-positive tumors.
    Hudelist G; Singer CF; Manavi M; Pischinger K; Kubista E; Czerwenka K
    Breast Cancer Res Treat; 2003 Aug; 80(3):353-61. PubMed ID: 14503808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth of human gastric carcinomas and expression of epidermal growth factor, transforming growth factor-alpha, epidermal growth factor receptor and p185c-erbB-2.
    Suzuki T; Tsuda T; Haruma K; Yoshihara M; Sumii K; Kajiyama G
    Oncology; 1995; 52(5):385-91. PubMed ID: 7637956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Domain-specific interactions between the p185(neu) and epidermal growth factor receptor kinases determine differential signaling outcomes.
    Qian X; O'Rourke DM; Fei Z; Zhang HT; Kao CC; Greene MI
    J Biol Chem; 1999 Jan; 274(2):574-83. PubMed ID: 9872991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.
    Tang CK; Gong XQ; Moscatello DK; Wong AJ; Lippman ME
    Cancer Res; 2000 Jun; 60(11):3081-7. PubMed ID: 10850460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are HER1/EGFR interactions with ligand free HER2 related to the effects of HER1-targeted drugs?
    Kurbel S
    Med Hypotheses; 2006; 67(6):1355-7. PubMed ID: 16890381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Y-box-binding protein 1 confers EGF independence to human mammary epithelial cells.
    Berquin IM; Pang B; Dziubinski ML; Scott LM; Chen YQ; Nolan GP; Ethier SP
    Oncogene; 2005 Apr; 24(19):3177-86. PubMed ID: 15735691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.